pmc logo image
Logo of annsurgJournal URL: http://www.annalsofsurgery.com

Formats:

Ann Surg. 1975 June; 181(6): 791–794.
PMCID: PMC1343895
Inherited antithrombin-III deficiency causing mesenteric venous infarction: a new clinical entity.
J C Gruenberg, R C Smallridge, and R D Rosenberg
Abstract
Primary superior mesenteric venous thrombosis is sometimes preceded by peripheral thrombophlebitis. Inherited antithrombin-III deficiency is a recently recognized autosomal dominant trait, which is characterized by thrombophlebitis and pulmonary embolism. This case report illustrates many features of both entities and strongly suggest a causal relationship. While long-term therapy has yet to be established, prophylactic therapy is recommended when asymptomatic individuals with known antithrombin-III deficiency are at increased risk of thrombosis. The efficacy of heparin alone has been unreliable, whereas Coumadin has been encouraging. Antithrombin-III concentrates are being developed and theoretically should be helpful. Patients with thrombophlebitis or pulmonary embolism should be suspected of having antithrombin-III deficiency. Such individuals also represent one mechanism to explain "primary" mesenteric venous thrombosis.
Full text
Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.4M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.
Images in this article
Click on the image to see a larger version.
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
  • Abildgaard U, Fagerhol MK, Egeberg O. Comparison of progressive antithrombin activity and the concentration of three thrombin inhibitors in human plasma. Scand J Clin Lab Invest. 1970 Dec;26(4):349–354. [PubMed]
  • Duckert F. Behaviour of antithrombin 3 in liver disease. Scand J Gastroenterol Suppl. 1973;19:109–112. [PubMed]
  • EGEBERG O. INHERITED ANTITHROMBIN DEFICIENCY CAUSING THROMBOPHILIA. Thromb Diath Haemorrh. 1965 Jun 15;13:516–530. [PubMed]
  • Fagerhol MK, Abildgaard U, Kornstad L. Antithrombin-3 concentration and ABO blood-groups. Lancet. 1971 Sep 18;2(7725):664–665. [PubMed]
  • Jona J, Cummins GM, Jr, Head HB, Govostis MC. Recurrent primary mesenteric venous thrombosis. JAMA. 1974 Mar 4;227(9):1033–1035. [PubMed]
  • Jordan PH, Boulafendis D, Guinn GA. Factors other than major vascular occlusion that contribute to intestinal infarction. Ann Surg. 1970 Feb;171(2):189–194. [PubMed]
  • Marciniak E, Farley CH, DeSimone PA. Familial thrombosis due to antithrombin 3 deficiency. Blood. 1974 Feb;43(2):219–231. [PubMed]
  • Mathews JE, White RR. Primary mesenteric venous occlusive disease. Am J Surg. 1971 Nov;122(5):579–583. [PubMed]
  • NAITOVE A, WEISMANN RE. PRIMARY MESENTERIC VENOUS THROMBOSIS. Ann Surg. 1965 Apr;161:516–523. [PubMed]
  • NORTH JP, WOLLENMAN OJ., Jr Venous mesenteric occlusion in the course of migrating thrombophlebitis. Surg Gynecol Obstet. 1952 Dec;95(6):665–671. [PubMed]
  • Rosenberg RD, Damus PS. The purification and mechanism of action of human antithrombin-heparin cofactor. J Biol Chem. 1973 Sep 25;248(18):6490–6505. [PubMed]
  • van der Meer J, Stoepman-van Dalen EA, Jansen JM. Antithrombin-3 deficiency in a Dutch family. J Clin Pathol. 1973 Jul;26(7):532–538. [PubMed]
  • Von Kaulla E, Von Kaulla KN. Antithrombin 3 and diseases. Am J Clin Pathol. 1967 Jul;48(1):69–80. [PubMed]
  • Wickerhauser M, Sgouris JT. Development of large-scale fractionation methods. II. Isolation of a factor IX concentrate (prothrombin complex) for clinical use. Vox Sang. 1972;22(2):137–160. [PubMed]